NICHOLAS TULSHI: Open Payments
NPI 1598380016 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 40 payments from 13 companies in 2025. Trend: 2023 $803 · 2024 $858 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $158 |
| ABBVIE INC. | 9 | $145 |
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Exact Sciences Corporation | 3 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: VRAYLAR, MOUNJARO, Ozempic, AIRSUPRA, Cologuard Collection Kit, Wegovy, GIVLAARI, CAPLYTA.
Industry payments across AL — which companies pay providers there.
